These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 3534992

  • 1. Perennial rhinitis treated with a new steroid: fluocortin butylester (FCB).
    Moesgaard-Nielsen V, Vinther B, Illum P, Harvig H.
    Rhinology; 1986 Sep; 24(3):175-9. PubMed ID: 3534992
    [Abstract] [Full Text] [Related]

  • 2. Grass pollen-induced hay fever treated with a new steroid fluocortin butylester (FCB).
    Moesgaard Nielsen V, Vinther B, Illum P.
    Rhinology; 1983 Sep; 21(3):257-63. PubMed ID: 6356306
    [Abstract] [Full Text] [Related]

  • 3. The protective action of fluocortin butylester (FCB) in the nasal antigen provocation test: a controlled double-blind, crossover study.
    Horak F, Matthes H.
    Ann Allergy; 1982 May; 48(5):305-8. PubMed ID: 7044195
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerance of fluocortin butyl administered twice daily in adult patients with perennial rhinitis.
    Hartley TF, Lieberman PL, Meltzer EO, Noyes JN, Pearlman DS, Tinkelman DG.
    J Allergy Clin Immunol; 1985 Apr; 75(4):501-7. PubMed ID: 3884690
    [Abstract] [Full Text] [Related]

  • 5. Multi-center, double-blind, placebo-controlled trial of fluocortin butyl in perennial rhinitis.
    Arbesman C, Bernstein IL, Bierman CW, Bocles JS, Katz R, Lieberman PL, Mattucci K, Meltzer EO, Middleton E, Noyes J, Pearlman DS, Pence HL, Slavin RG, Spector SL.
    J Allergy Clin Immunol; 1983 Jun; 71(6):597-603. PubMed ID: 6343462
    [Abstract] [Full Text] [Related]

  • 6. [Clinical trial of fluocortin butylester in a double-blind contralateral comparison versus fluocortolone and hydrocortisone acetate (author's transl)].
    Reckers R.
    Arzneimittelforschung; 1977 Jun; 27(11a):2240-4. PubMed ID: 341901
    [Abstract] [Full Text] [Related]

  • 7. Intranasal fluocortin butyl in patients with perennial rhinitis: a 12-month efficacy and safety study including nasal biopsy.
    Orgel HA, Meltzer EO, Bierman CW, Bronsky E, Connell JT, Lieberman PL, Nathan R, Pearlman DS, Pence HL, Slavin RG.
    J Allergy Clin Immunol; 1991 Aug; 88(2):257-64. PubMed ID: 1880325
    [Abstract] [Full Text] [Related]

  • 8. Allergic perennial and non-allergic, vasomotor rhinitis treated with budesonide nasal spray.
    Balle VH, Pedersen U, Engby B.
    Rhinology; 1980 Sep; 18(3):135-42. PubMed ID: 6997974
    [Abstract] [Full Text] [Related]

  • 9. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group.
    Mandl M, Nolop K, Lutsky BN.
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):237-45. PubMed ID: 9305231
    [Abstract] [Full Text] [Related]

  • 10. Assessment of the correlation of rhinometry with the symptoms and signs of allergic rhinitis in children.
    Welch MJ, Meltzer EO, Orgel HA, Kemp JP.
    Ann Allergy; 1985 Oct; 55(4):577-9. PubMed ID: 3901833
    [Abstract] [Full Text] [Related]

  • 11. Clinical data of fluocortin butylester (FCB) - a new inhalable corticoid.
    Chen-Walden H.
    Z Erkr Atmungsorgane; 1981 Oct; 157(3):287-90. PubMed ID: 7340214
    [Abstract] [Full Text] [Related]

  • 12. Double-blind assessment of azelastine in the treatment of perennial allergic rhinitis.
    Grossman J, Halverson PC, Meltzer EO, Shoenwetter WF, van Bavel JH, Woehler TR, Freitag JJ, Hemsworth GR.
    Ann Allergy; 1994 Aug; 73(2):141-6. PubMed ID: 8067597
    [Abstract] [Full Text] [Related]

  • 13. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis.
    Lee DK, Gray RD, Robb FM, Fujihara S, Lipworth BJ.
    Clin Exp Allergy; 2004 Apr; 34(4):646-9. PubMed ID: 15080820
    [Abstract] [Full Text] [Related]

  • 14. The effect of budesonide in perennial rhinitis.
    Balle VH.
    Eur J Respir Dis Suppl; 1982 Apr; 122():197-204. PubMed ID: 6754416
    [Abstract] [Full Text] [Related]

  • 15. The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis.
    Davies RJ, Lund VJ, Harten-Ash VJ.
    Rhinology; 1993 Dec; 31(4):159-64. PubMed ID: 7908144
    [Abstract] [Full Text] [Related]

  • 16. A clinical evaluation of N-5' with perennial-type allergic rhinitis--a test by the multi-clinic, intergroup, double-blind comparative method.
    Okuda M, Ishikawa T, Saito Y, Shimizu T, Baba S.
    Ann Allergy; 1984 Aug; 53(2):178-85. PubMed ID: 6205614
    [Abstract] [Full Text] [Related]

  • 17. Combined mediator blockade or topical steroid for treating the unified allergic airway.
    Barnes ML, Menzies D, Fardon TC, Burns P, Wilson AM, Lipworth BJ.
    Allergy; 2007 Jan; 62(1):73-80. PubMed ID: 17156345
    [Abstract] [Full Text] [Related]

  • 18. Budesonide - a new nasal steroid.
    Pipkorn U, Rundcrantz H, Lindqvist N.
    Rhinology; 1980 Dec; 18(4):171-5. PubMed ID: 7010515
    [Abstract] [Full Text] [Related]

  • 19. A study of the effect of nasal steroid sprays in perennial allergic rhinitis patients with rhinitis medicamentosa.
    Ferguson BJ, Paramaesvaran S, Rubinstein E.
    Otolaryngol Head Neck Surg; 2001 Sep; 125(3):253-60. PubMed ID: 11555762
    [Abstract] [Full Text] [Related]

  • 20. Effect of nasal steroid treatment on airway inflammation determined by exhaled nitric oxide in allergic schoolchildren with perennial rhinitis and asthma.
    Pedroletti C, Lundahl J, Alving K, Hedlin G.
    Pediatr Allergy Immunol; 2008 May; 19(3):219-26. PubMed ID: 18399898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.